Janux Therapeutics Inc. JANX is a biotechnology company specializing in the development of novel cancer immunotherapies designed to enhance the body’s ability to harness the immune system to combat cancer. The company focuses on creating therapies that are not only effective but also have reduced side effects, improving patient outcomes in the fight against cancer. […]
Read MoreADC Therapeutics focuses on advancing its proprietary antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors. Its flagship product is ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S. Food and Drug Administration and conditional approval from the European Commission for the treatment of […]
Read MoreJasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and novel conditioning regimens for stem cell transplantation and ex-vivo gene therapy, a technique […]
Read MoreQudian Inc. (QD) Qudian Inc. operates as a consumer-oriented technology company in the People’s Republic of China. It engages in the operation of online platforms to provide small consumer credit products, as well as provides technology development and services and research and development services. Afya Limited (AFYA) Afya Limited, through its subsidiaries, operates as a […]
Read MoreImmunityBio, Inc. (IBRX) ImmunityBio, Inc., a clinical-stage biotechnology company, engages in developing therapies and vaccines that complement, harness, and amplify the immune system to defeat cancers and infectious diseases in the United States and Europe. Super Micro Computer, Inc. (SMCI) Super Micro Computer, Inc., together with its subsidiaries, develops and manufactures high performance server and storage solutions […]
Read MoreSavara is a clinical-stage biopharmaceutical company focused on rare respiratory diseases. Their lead product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Autoimmune PAP is a disease that belongs to a family of distinct, rare lung diseases collectively referred to as PAP. Autoimmune PAP […]
Read MoreShattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company’s lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. The company was incorporated in 2016 and is headquartered in […]
Read MoreImmunoGen, Inc. (IMGN) ImmunoGen, Inc., a commercial-stage biotechnology company, focuses on developing and commercializing the antibody-drug conjugates (ADCs) for cancer patients. Abercrombie & Fitch Co. (ANF) Abercrombie & Fitch Co., through its subsidiaries, operates as a specialty retailer in the United States, Europe, the Middle East, Asia, the Asia-Pacific, Canada, and internationally. XPO, Inc. (XPO) […]
Read MoreOlema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal […]
Read MoreCabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. The company’s lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease.
Read MoreQuanterix Corporation (QTRX) Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics. Cabaletta Bio, Inc. (CABA) Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated […]
Read MoreAbercrombie & Fitch Co. (ANF) Abercrombie & Fitch Co., through its subsidiaries, operates as a specialty retailer in the United States, Europe, the Middle East, Asia, the Asia-Pacific, Canada, and internationally. Savara Inc. (SVRA) Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Limbach Holdings, Inc. (LMB) Limbach Holdings, Inc. operates as […]
Read MoreThrough its subsidiaries, offers energy storage products and services, and artificial intelligence enabled digital applications for renewables and storage applications FLNC $26.5000 -0.7100 % -2.6100 Fluence Energy Inc Cl A Sector : Oils-Energy Industry : Other Alt Energy Signal Short Term Trend Long Term Trend BUY UP UP Day: -2.61% Wk: 7.42% Mo: 15.74% Yrly: […]
Read MoreA clinical-stage company, engages in the development of transformational treatments for patients with serious metabolic diseases, including non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. AKRO $53.7000 -1.5100 % -2.7400 Akero Therapeutics Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: -2.74% Wk: […]
Read MoreBuy Price: $13.00 or better Sell Price: Traderspro Sell Signal Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The stocks found in the One Hot Stock category use stocks that are in long term, short term trends and are early in the buy signal trend. Suggested buy prices are […]
Read More